Maintenance work on the ZORA database servers is scheduled for Thursday 25th July 2019 from 19:00-20:00. During this period ZORA and JDB will not be available. Thank you for your understanding.
Ummanni, R; Duscharla, D; Barett, C; Venz, S; Schlomm, T; Heinzer, H; Walther, R; Bokemeyer, C; Brümmendorf, T H; Murthy, P V; Balabanov, S (2015). Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers. Journal of Proteomics, 119:218-229.
Honecker, F; Rohlfing, T; Harder, S; Braig, M; Gillis, A J; Glaesener, S; Barett, C; Bokemeyer, C; Buck, F; Brümmendorf, T H; Looijenga, L H; Balabanov, S (2014). Proteome analysis of the effects of all-trans retinoic acid on human germ cell tumor cell lines. Journal of Proteomics, 96:300-313.
Balabanov, S; Wilhelm, T; Venz, S; Keller, G; Scharf, C; Pospisil, H; Braig, M; Barett, C; Bokemeyer, C; Walther, R; Brümmendorf, T H; Schuppert, A (2013). Combination of a proteomics approach and reengineering of meso scale network models for prediction of mode-of-action for tyrosine kinase inhibitors. PLoS ONE, 8(1):e53668.
Ummanni, R; Barreto, F; Venz, S; Scharf, C; Barett, C; Mannsperger, H A; Brase, J C; Kuner, R; Schlomm, T; Sauter, G; Sültmann, H; Korf, U; Bokemeyer, C; Walther, R; Brümmendorf, T H; Balabanov, S (2012). Peroxiredoxins 3 and 4 are overexpressed in prostate cancer tissue and affect the proliferation of prostate cancer cells in vitro. Journal of Proteome Research, 11(4):2452-2466.